Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Safety and Error PreventionMedicationIssue 724

Emergency Recall of the OTC Weight-loss Drug Alli

Several reports of tampering have been made nationwide.... 

Advertisement

Multiple reports of tampered Alli products have been reported throughout the United States, prompting an emergency recall of this OTC weight-loss drug.

Reports of tampered bottles containing different types of pills, in various shapes and colors, first began to pour in on Wednesday from consumers in Alabama, Florida, Louisiana, Mississippi, New York, North Carolina and Texas. Many of these bottles were missing labels, packed in a sealed box, and had tamper-evident seals that did not appear genuine.

The manufacturer, GlaxoSmithKline, is currently working with the U.S. Food and Drug Administration in their investigation. The stage in the supply chain where the productions were tampered with still remains unknown.

Product tampering is a serious crime in America and finding the source of this is essential. According to a spokeswoman for GlaxoSmithKline, "The investigation is ongoing... We've asked people to return bottles to us, so we can examine them very closely ... we don't have any theories at this point."

The contents found within the tampered Alli products are currently unknown. As of now, at least 20 inquiries have been made. No reports of harm have been reported.

Practice Pearls:
  • Alli is an OTC weight-loss supplement currently approved for obesity in adults in conjunction with a healthy diet
  • Weight-loss supplements are popular throughout the U.S. and many patients may be using them
  • Anyone who has purchased Alli® and believes it has been tampered with should contact the FDA and manufacture immediately

Hirschler B, Goodman D. GSK recalls weight-loss drug Alli in U.S. on tampering concerns. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 10 April, 2014 and appeared in  Safety and Error PreventionMedicationIssue 724

Past five issues: Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 | Diabetes Clinical Mastery Series Issue 223 |

2014 Most Popular Articles:

Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014
Handbook of Diabetes, 4th Ed., Excerpt #25: Specific Circumstances that Affect Diabetes Control
Posted January 04, 2015
FDA Approves Weight-management Drug Saxenda
Posted December 26, 2014
Advancement in the Artificial Pancreas
Posted December 26, 2014
Dr. Timothy Garvey on Qsymia and Other New Therapies for Weight Loss
Posted January 12, 2015
Type 2 Diabetes Risk Lower for Blood Type O
Posted December 26, 2014
Increased Mortality with Combining Sulfonylurea and Insulin
Posted December 26, 2014
Early Insulin Therapy Makes an Impact
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are you comfortable recommending one of the 4 new FDA-approved weight loss drugs?
CME/CE of the Week
Molly Gee, MEd, RD

Category: Nutrition
Credits: .5



Search Articles On Diabetes In Control